EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSCCRG00000081032
Gene Symbol: HDAC11
1 Cross references
197 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCCRG00000043037
Gene Symbol: HDAC4
1 Cross references
200 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCCRG00000001231
Gene Symbol: HDAC4
1 Cross references
199 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCCRG00000053840
Gene Symbol: HDAC8
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCCRG00000026960
Gene Symbol: HDAC8
1 Cross references
202 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCCRG00000065953
Gene Symbol: HCN4
1 Cross references
215 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSCCRG00000014346
Gene Symbol: HCRTR2
1 Cross references
198 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSCCRG00000069172
Gene Symbol: HCRTR2
1 Cross references
198 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCCRG00000043515
Gene Symbol: IKBKB
1 Cross references
196 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCCRG00000010485
Gene Symbol: IKBKB
1 Cross references
195 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSCCRG00000029353
Gene Symbol: INSRA
1 Cross references
228 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSCCRG00000039595
Gene Symbol: INSRA
1 Cross references
228 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).